About: Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1965

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1965 (uk) scientific article published on 01 October 1965 (en) im Oktober 1965 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1965 (ast)
publication date	wds:Q71159939-66E5A508-C9DF-4639-BB2E-AEC6525926E2
publication date	1965-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71159939-4DFC021D-F45B-4F8A-AE80-D7EA440B20C5
language of work or name	English
cites work	wds:Q71159939-03BD7BCC-2EA2-4E1A-9501-49F34DE5D158 wds:Q71159939-0CA1C1A1-7923-44A8-89B6-36DAAA421B75 wds:Q71159939-2EBFF5FA-9721-4A83-B823-058992C96B6D wds:Q71159939-3BD44213-EC99-46DA-83A1-7A478665D0F9 wds:Q71159939-62A83FA5-474D-4F97-AE5B-5306A5E81C32 wds:Q71159939-6FF6568D-B306-48EE-A371-A0E2C6A0FE38 wds:Q71159939-7129E83E-BB21-4087-B4C7-AE4EC154ADE7 wds:Q71159939-77BB29C9-FA38-48DA-A6C7-E41AD8F69BA3 wds:Q71159939-81034E97-0F6F-4B1B-BD95-B721047D8A09 wds:Q71159939-8618A341-CCB6-4066-879A-10704C4B52EE wds:Q71159939-92E3532F-846D-42BD-89F6-6667DAA535A2 wds:Q71159939-949DFA08-024C-4EDB-A72C-867655CF02AC wds:Q71159939-979A27BE-E1F7-4B24-97A2-3F11806CF9B8 wds:Q71159939-BEDDAFBE-27C1-45AB-A570-78864E9117B2 wds:Q71159939-C06F0E62-E373-4C85-94B0-7A96A2DCD8BE wds:Q71159939-DAF83FCD-586E-4D03-BC88-2FCF24D155EE wds:Q71159939-DE713EEE-EC24-456F-BEA9-A1539C753785 wds:Q71159939-F0DA5548-099B-4FA0-A59F-6EDDF729EA3F
cites work	Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer DIMETHYL SULFOXIDE (DMSO): A NEW CONCEPT IN PHARMACOTHERAPY Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report The treatment of human cancer with intra-arterial nitrogen mustard, methylbis (2-chloroethyl) amine hydrochloride, utilizing a simplified catheter technique Perfusion and infusion techniques in cancer chemotherapy Intra-arterial catheterization of viscera in man An abdominal tourniquet for regional chemotherapy. The use of intravascular balloon catheters for isolation of the pelvic vascular bed during pump-oxygenator perfusion of cancer chemotherapeutic agents Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets Effective use of a new alkylating agent in doses lethal to bone marrow with protection by tourniquets of marrow in the extremis ENZYME-ALTERABLE ALKYLATING AGENTS. VII. THE DESIGN OF SHORT-LIVED MUSTARDS CLINICAL EXPERIENCE WITH N-HEXAMETHYLENE N'N'-DIETHYLENE THIOPHOSPHORAMIDE (KC-33), A NEW AGENT FOR BREAST AND OVARIAN CARCINOMA Enzyme alterable alkylating agents: a new approach to regional chemotherapy by intra-arterial infusion of new short-lived alkylating agents New short half-life alkylating agents for intra-arterial regional chemotherapy ENZYME ALTERABLE ALKYLATING AGENTS. V. DESIGN OF SULFUR MUSTARDS WITH VARYING DEGREES OF HYDROLYTIC STABILITY IN A SEARCH FOR SHORT BIOLOGICAL HALF-LIFE AGENTS Continuous arterial infusion of methotrexate with intermittent, intramuscular citrovorum factor therapy in head and neck cancer Enzyme-alterable alkylating agents. IV. Treatment of cancer in children with repetitive massive doses of S-46, protecting the extremity marrow by tourniquets
author name string	wds:Q71159939-0BE0B295-6117-4285-BB00-048AE12016EB wds:Q71159939-14935FB0-D67C-406B-960E-E7B3B408A6EF wds:Q71159939-165D2639-0063-42F6-AC60-14B8AFEEC848 wds:Q71159939-243324B6-4F9D-4789-8B2A-4B26472CB972 wds:Q71159939-4044CD75-B9C7-4C96-A9E7-8A83DBEA3B7F wds:Q71159939-4CD39F3E-11A7-4D73-8384-ABD751B0F886 wds:Q71159939-5C5981AD-4BBF-44F7-9043-6D813A17FA7D wds:Q71159939-8B65DBD4-9B60-4FEA-B1D1-BF7C11350E40 wds:Q71159939-9CB44F09-0520-442A-BCA6-9575FC73FAAB wds:Q71159939-ACAD2AE2-F4F6-4EAF-96E9-121C44C63B66 wds:Q71159939-D371EA7F-AD72-4A9C-9C11-2C041A93B666 wds:Q71159939-D4594538-53F5-47ED-B113-44FD3C069B09 wds:Q71159939-F2193484-0DD7-4562-9E2F-6D05DAB917B5
author name string	L E Goodman S Calle A M Seligman S J Abrams S P Kramer R L Hirschfeld A B Flores C E Williamson A Ulfohn B Witten S Sass D Bakal E H Cendana
rdfs:label	Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second (en) Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second (nl)
skos:prefLabel	Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second (en) Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second (nl)
name	Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second (en) Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second (nl)
title	wds:Q71159939-AABFE157-9B14-42B2-A7D4-4D4AF914DE01
title	Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second (en)
page(s)	wds:Q71159939-F35FD3AA-A423-4AE8-BCB5-20D18A27565B
page(s)	663-689
instance of	wds:Q71159939-523DD045-7777-4D29-A432-3226A6CEE66B
instance of	scholarly article
PubMed ID	wds:Q71159939-9A11C2C1-1A38-441C-B6E3-C247E9D5B394
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5319397
PubMed ID	5319397
published in	wds:Q71159939-D05EFA59-2FB5-4B53-AEA9-362EF3248C6A
published in	Annals of Surgery
issue	wds:Q71159939-84B1F0CE-B7C8-4560-8AD3-9114BDA1C382
volume	wds:Q71159939-C837BDE6-ADB6-4088-8ACD-E773EBC6705F
issue	4
volume	162
DOI	wds:Q71159939-B6B4F293-2948-4716-B065-AC00973AEDF4
DOI	http://dx.doi.org/10.1097/00000658-196510000-00011
DOI	10.1097/00000658-196510000-00011
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71159939
is cites work of	Enzyme alterable alkylating agents. XI. Clinical trials of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy Preliminary study of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy The clinical trial of an alkylating agent with a short half-life designed for intra-arterial chemotherapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software